BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9557744)

  • 1. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV; Kodihalli S; Govorkova EA; Fanget B; Gerdil C; Webster RG
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S; Justewicz DM; Gubareva LV; Webster RG
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM; Webster RG
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Buffin S; Peubez I; Barrière F; Nicolaï MC; Tapia T; Dhir V; Forma E; Sève N; Legastelois I
    Vaccine; 2019 Oct; 37(46):6857-6867. PubMed ID: 31590935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
    Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
    J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.
    Govorkova EA; Murti G; Meignier B; de Taisne C; Webster RG
    J Virol; 1996 Aug; 70(8):5519-24. PubMed ID: 8764064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
    Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
    Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
    Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.
    Harmon MW; Rota PA; Walls HH; Kendal AP
    J Clin Microbiol; 1988 Feb; 26(2):333-7. PubMed ID: 3343328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM; Oxford JS; Dunleavy U; Newman RW; Major D; Robertson JS
    Virology; 1989 Jul; 171(1):214-21. PubMed ID: 2741341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chitosan as an adjuvant for inactivated vaccines against avian influenza viruses].
    Gendon IuZ; Vasil'ev IuM; Markushin SG; Akopova II; Koptiaeva IB; Krivtsov GG
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):40-7. PubMed ID: 19459476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Egg-Derived Sulfated
    Guthmiller JJ; Utset HA; Henry C; Li L; Zheng NY; Sun W; Costa Vieira M; Zost S; Huang M; Hensley SE; Cobey S; Palese P; Wilson PC
    mBio; 2021 Jun; 12(3):e0083821. PubMed ID: 34126773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.